ETRETINATE

Etretinate is a systemic retinoid used for psoriasis, normalizing epidermal cell proliferation. Side effects include dry skin, teratogenicity, and elevated lipids.

SKU: 9e9bb0954427 Category: Tag:

Product Description


Mechanism of Action

Etretinate is a lipophilic aromatic retinoid that binds nuclear RAR/RXR receptors, altering gene transcription involved in epithelial differentiation and keratinization. It accumulates in adipose tissue with a very long biological half‑life.

Benefits and Advantages

Used in retinoid‑receptor research, keratinocyte differentiation studies, autoimmune skin‑disease modelling, and gene‑regulation assays.

Side Effects and Risks

Risks include teratogenicity, hepatotoxicity, hyperlipidemia, mucocutaneous dryness and photosensitivity. Handle with high‑potency retinoid precautions.

Datasheet


Molecular Formula

C23H30O3

Molecular Weight

354.5 g/mol

CAS Number

54350-48-0

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

etretinate; 54350-48-0; Tegison; Ethyl etrinoate; Etretinato

IUPAC/Chemical Name

ethyl (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate

InChl Key

HQMNCQVAMBCHCO-DJRRULDNSA-N

InChl Code

InChI=1S/C23H30O3/c1-8-26-23(24)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(25-7)20(6)19(21)5/h9-15H,8H2,1-7H3/b11-9+,13-12+,16-10+,17-14+

References

https://pubchem.ncbi.nlm.nih.gov/compound/5282375;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download